Late-Breaking scientific poster at the American Thoracic ... to benefit the prevention and treatment of acute respiratory distress syndrome (ARDS). Vasomune and co-development partner AnGes ...

or acute respiratory distress syndrome (ARDS) represent an important subset in which substantial controversy exists. ALI is defined as acute respiratory failure with bilateral pulmonary ...

Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that the ...